Immucell ICCC
NASDAQ ICCC
$10.50 +0.05 (+0.48%)
As of: Oct 21, 2026 · 10:01 AM EDT

Immucell (ICCC) Other Non-Current Liabilities (2017 - 2023)

Updated

Immucell (ICCC) reported Other Non-Current Liabilities of $9.26 million for Q2 2023, down 3.3% from the prior quarter.

Analysis

Immucell (ICCC) Other Non-Current Liabilities (2017 - 2023) Analysis & Trends

At the end of FY2019, Immucell posted Other Non-Current Liabilities of $58,526.

  • By year, Other Non-Current Liabilities came in at $996.00 in FY2017.
  • The Q2 2023 figure ranks as the lowest quarterly Other Non-Current Liabilities since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.91 Bn 1,101.50 Bn 19.71 Bn
2 Johnson & Johnson 615.07 Bn 533.59 Bn 17.26 Bn
3 AbbVie 505.92 Bn 479.03 Bn 12.70 Bn
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn
5 Novartis Ag 298.25 Bn 262.24 Bn 11.24 Bn
6 Astrazeneca 261.76 Bn 235.45 Bn 12.86 Bn
7 Amgen 236.19 Bn 191.59 Bn 7.24 Bn
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn
10 Immucell 95.18 Mn 72.63 Mn 2.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 9.26 Mn
Mar 31, 2023 9.58 Mn
Dec 31, 2019 58,526.00
Sep 30, 2019 86,973.00
Jun 30, 2019 57,216.00
Dec 31, 2017 996.00
API Access

Immucell Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ICCC&period=max&api_key=YOUR_API_KEY